Doctors are increasingly detecting stomach tumors at an early stage, new research finds, raising hopes for treatment for one ...

Abstract Title：Global multi-center phase I trial of the intraperitoneal infusion of anti-EpCAM x anti-CD3 bispecific antibody catumaxomab for advanced gastric ... 5.6% of all cancer diagnoses ...

Experts are reaching consensus about screening and surveillance for high-risk patients, similar to guidelines for the colon ...

A genetic signature including four genes in gastric cancer is linked to an increase in recurrence and mortality.

"Not all stomach cancers are equal," lead researcher Dr. Ulysses Ribeiro, a professor at the São Paulo State Cancer Institute ...